[Mycobacterium tuberculosis with initial drug resistance in silicotuberculosis and pulmonary tuberculosis patients]. 1982

P S Beskrovnyĭ, and Iu S Varenko, and T A Revenko

UI MeSH Term Description Entries
D009169 Mycobacterium tuberculosis A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation. Mycobacterium tuberculosis H37Rv
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular
D012830 Silicotuberculosis Pulmonary or extrapulmonary infection caused by MYCOBACTERIUM TUBERCULOSIS or nontuberculous mycobacteria in a patient with silicosis. Silicotuberculoses
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D014397 Tuberculosis, Pulmonary MYCOBACTERIUM infections of the lung. Pulmonary Consumption,Pulmonary Phthisis,Pulmonary Tuberculoses,Pulmonary Tuberculosis,Tuberculoses, Pulmonary,Consumption, Pulmonary,Consumptions, Pulmonary,Phthises, Pulmonary,Phthisis, Pulmonary,Pulmonary Consumptions,Pulmonary Phthises

Related Publications

P S Beskrovnyĭ, and Iu S Varenko, and T A Revenko
April 2001, Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases,
P S Beskrovnyĭ, and Iu S Varenko, and T A Revenko
January 1964, Problemy tuberkuleza,
P S Beskrovnyĭ, and Iu S Varenko, and T A Revenko
July 2013, The Indian journal of tuberculosis,
P S Beskrovnyĭ, and Iu S Varenko, and T A Revenko
November 1997, Journal of the Formosan Medical Association = Taiwan yi zhi,
P S Beskrovnyĭ, and Iu S Varenko, and T A Revenko
January 2009, Problemy tuberkuleza i boleznei legkikh,
P S Beskrovnyĭ, and Iu S Varenko, and T A Revenko
September 1968, Vrachebnoe delo,
P S Beskrovnyĭ, and Iu S Varenko, and T A Revenko
January 1971, Problemy tuberkuleza,
P S Beskrovnyĭ, and Iu S Varenko, and T A Revenko
January 1970, Problemy tuberkuleza,
P S Beskrovnyĭ, and Iu S Varenko, and T A Revenko
January 1998, Annali italiani di medicina interna : organo ufficiale della Societa italiana di medicina interna,
Copied contents to your clipboard!